Baidu
map

MedSci获启明创投A轮投资,强化移动医疗深度布局

2015-03-06 佚名 美通社

2015年3月,中国大型医疗互联网公司MedSci(梅斯医药)宣布获得中国领先风险投资机构启明创投的数千万美元投资,这也是国内专业医疗互联网服务领域大型A轮融资之一。MedSci是国内专业临床研究与学术服务机构。接受投资后的MedSci(梅斯医药)将在移动医疗服务、多渠道传播(MCM)服务领域持续发力,为医疗、生物医药领域的科研、临床医生,以及产业界人士提供更好的产品和服务。同时,公司还拥有生物谷

2015年3月,中国大型医疗互联网公司MedSci(梅斯医药)宣布获得中国领先风险投资机构启明创投的投资,这也是国内专业医疗互联网服务领域大型A轮融资之一。

MedSci是国内专业临床研究与学术服务机构。接受投资后的MedSci(梅斯医药)将在移动医疗服务、多渠道传播(MCM)服务领域持续发力,为医疗、生物医药领域的科研、临床医生,以及产业界人士提供更好的产品和服务。同时,公司还拥有生物谷平台,是中国生物医药产业最大的行业平台,为生物医药产业提供专业产品和服务。

MedSci董事长张发宝博士表示,医疗正面临新的时代,医学知识体系正被大数据、精准医疗所重构,而移动化极大提升知识传递速度、提高医疗协同与效率。基于医疗知识体系的重构和移动端的医疗解决方案,正成为医疗行业变革新的契机。MedSci将重点打造基于医学知识体系和移动化解决方案的服务,将云、大数据、移动技术与医疗结合,全面提升医疗行业效率,解决临床医疗与临床研究中难题,让医疗更便捷,更精准。

通过资金的注入,MedSci将全面加强移动医疗业务,实现多终端多渠道全行业贯通,并通过云端的知识管理系统,助力医生及科研工作者的职业发展。同时,整合医学资源与渠道,为制药企业提供高效的销售和市场解决方案、支持临床决策的医学传播体系、专业的医学继续教育平台以及客制化会议培训服务。

张发宝博士还表示,“经过2年多的探索和发展,MedSci多渠道传播(MCM)和E-Marketing服务已经与辉瑞、强生等跨国药企开展了合作。2015年,我们将全力提升产品体验与质量,为客户创造更多的价值。在移动医疗时代,移动是工具,而医学是基石。以专业的医学团队作为基石,移动医疗才有安全可靠的翅膀。我们很骄傲我们的团队、成绩和潜力得到了启明创投的认可,我们继续在医疗服务领域提供高品质服务,为移动医疗的发展提供基石。”

“多年来,启明一直为年轻的中国企业提供所需要的投资者价值,并努力成为中国创业家的顶级的投资伙伴。启明创投对MedSci医学和生物谷关注已久。作为国内生物医药和医疗领域的专业服务机构,梅斯医药在临床医生群体与生物科研领域拥有很高影响力和良好口碑。”启明创投医疗合伙人胡旭波表示,“结合启明创投在医疗领域的成功投资经验和一流的投资团队,我们有信心共同推动整个医疗行业高速健康发展。”

关于启明创投


启明创投成立于2006年,是一家中国领先的风险投资机构。在上海,北京,香港,苏州,西雅图设有办公室。启明创投旗下管理四支美元基金和两支人民币基金,总计管理规模超过16亿美元。专注于互联网及消费品、医疗健康,信息技术、以及清洁能源环保技术行业早期和成长期企业的投资。启明创投汇聚了30余位资深投资人团队,拥有非常丰富的企业管理和风险投资经验。启明创投已投资超过100家企业,其中许多企业已经成功上市或并购。启明已在业界树立了良好的声誉,为年轻的中国企业提供所需要的投资者价值,并努力成为中国创业家的顶级的投资伙伴。详情请访问:http://www.qimingventures.com/


关于MedSci医学平台

MedSci是专业临床研究与学术服务平台,专注临床研究与临床知识传播,推动中国临床研究规范化、智能化和成果国际化,从事临床研究设计、统计与培训服务等业务,结合移动平台,为临床研究提供线上与线下整体解决方案。目前拥有超过150万专业用户,其中中高端医生会员50余万。

详情请访问:http://www.MedSci.cn/ ,或者微信关注:MedSci_cn,或下载MedSci APP
 
MedSci APP 下载二维码 MedSci微信二维码


关于生物谷

生物谷是国内生物行业的最大综合服务商。生物谷一直深耕于生物医药领域,已成为生物医药行业平台。为生物科技企业、产业园区和研究机构,提供全面的会议、咨询、行业分析、医药外包服务,拥有国内最大的产业核心数据库,提供领先、精准、高效地服务体系和解决方案。
 
详情请访问:http://www.bioon.com/ ,或者微信关注:bioonnews,或下载生物谷APP
 
生物谷 APP 下载二维码 生物谷 微信二维码
 

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (8)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=34935, encodeId=bb3334935b9, content=投资很大哦, beContent=null, objectType=article, channel=null, level=null, likeNumber=201, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=332823945, createdName=hlycom3356, createdTime=Thu Aug 06 20:39:00 CST 2015, time=2015-08-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=17937, encodeId=4bd81e93714, content=恭喜!, beContent=null, objectType=article, channel=null, level=null, likeNumber=200, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=MedSci客户端网友, createdTime=Sun Mar 08 12:52:00 CST 2015, time=2015-03-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=17938, encodeId=97ff1e938bd, content=希望越做越好!, beContent=null, objectType=article, channel=null, level=null, likeNumber=155, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=MedSci客户端网友, createdTime=Sun Mar 08 12:52:00 CST 2015, time=2015-03-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=17924, encodeId=c82a1e9247b, content=恭喜MedSci, beContent=null, objectType=article, channel=null, level=null, likeNumber=146, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=223.104.5.**, createdTime=Sun Mar 08 10:33:00 CST 2015, time=2015-03-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1530405, encodeId=61cc153040507, content=<a href='/topic/show?id=8309e5153aa' target=_blank style='color:#2F92EE;'>#移动医疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=75153, encryptionId=8309e5153aa, topicName=移动医疗)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fbd812108434, createdName=yahu, createdTime=Sun Mar 08 05:09:00 CST 2015, time=2015-03-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1606427, encodeId=5493160642ed5, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Sun Mar 08 05:09:00 CST 2015, time=2015-03-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=17869, encodeId=8e761e86917, content=恭喜medsci, beContent=null, objectType=article, channel=null, level=null, likeNumber=134, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=drhqh240, createdTime=Sat Mar 07 15:20:00 CST 2015, time=2015-03-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=17837, encodeId=87ba1e837bd, content=有市场, beContent=null, objectType=article, channel=null, level=null, likeNumber=153, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=hbwang006, createdTime=Fri Mar 06 19:20:00 CST 2015, time=2015-03-06, status=1, ipAttribution=)]
    2015-08-06 hlycom3356

    投资很大哦

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=34935, encodeId=bb3334935b9, content=投资很大哦, beContent=null, objectType=article, channel=null, level=null, likeNumber=201, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=332823945, createdName=hlycom3356, createdTime=Thu Aug 06 20:39:00 CST 2015, time=2015-08-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=17937, encodeId=4bd81e93714, content=恭喜!, beContent=null, objectType=article, channel=null, level=null, likeNumber=200, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=MedSci客户端网友, createdTime=Sun Mar 08 12:52:00 CST 2015, time=2015-03-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=17938, encodeId=97ff1e938bd, content=希望越做越好!, beContent=null, objectType=article, channel=null, level=null, likeNumber=155, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=MedSci客户端网友, createdTime=Sun Mar 08 12:52:00 CST 2015, time=2015-03-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=17924, encodeId=c82a1e9247b, content=恭喜MedSci, beContent=null, objectType=article, channel=null, level=null, likeNumber=146, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=223.104.5.**, createdTime=Sun Mar 08 10:33:00 CST 2015, time=2015-03-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1530405, encodeId=61cc153040507, content=<a href='/topic/show?id=8309e5153aa' target=_blank style='color:#2F92EE;'>#移动医疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=75153, encryptionId=8309e5153aa, topicName=移动医疗)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fbd812108434, createdName=yahu, createdTime=Sun Mar 08 05:09:00 CST 2015, time=2015-03-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1606427, encodeId=5493160642ed5, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Sun Mar 08 05:09:00 CST 2015, time=2015-03-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=17869, encodeId=8e761e86917, content=恭喜medsci, beContent=null, objectType=article, channel=null, level=null, likeNumber=134, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=drhqh240, createdTime=Sat Mar 07 15:20:00 CST 2015, time=2015-03-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=17837, encodeId=87ba1e837bd, content=有市场, beContent=null, objectType=article, channel=null, level=null, likeNumber=153, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=hbwang006, createdTime=Fri Mar 06 19:20:00 CST 2015, time=2015-03-06, status=1, ipAttribution=)]
    2015-03-08 MedSci客户端网友

    恭喜!

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=34935, encodeId=bb3334935b9, content=投资很大哦, beContent=null, objectType=article, channel=null, level=null, likeNumber=201, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=332823945, createdName=hlycom3356, createdTime=Thu Aug 06 20:39:00 CST 2015, time=2015-08-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=17937, encodeId=4bd81e93714, content=恭喜!, beContent=null, objectType=article, channel=null, level=null, likeNumber=200, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=MedSci客户端网友, createdTime=Sun Mar 08 12:52:00 CST 2015, time=2015-03-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=17938, encodeId=97ff1e938bd, content=希望越做越好!, beContent=null, objectType=article, channel=null, level=null, likeNumber=155, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=MedSci客户端网友, createdTime=Sun Mar 08 12:52:00 CST 2015, time=2015-03-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=17924, encodeId=c82a1e9247b, content=恭喜MedSci, beContent=null, objectType=article, channel=null, level=null, likeNumber=146, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=223.104.5.**, createdTime=Sun Mar 08 10:33:00 CST 2015, time=2015-03-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1530405, encodeId=61cc153040507, content=<a href='/topic/show?id=8309e5153aa' target=_blank style='color:#2F92EE;'>#移动医疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=75153, encryptionId=8309e5153aa, topicName=移动医疗)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fbd812108434, createdName=yahu, createdTime=Sun Mar 08 05:09:00 CST 2015, time=2015-03-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1606427, encodeId=5493160642ed5, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Sun Mar 08 05:09:00 CST 2015, time=2015-03-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=17869, encodeId=8e761e86917, content=恭喜medsci, beContent=null, objectType=article, channel=null, level=null, likeNumber=134, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=drhqh240, createdTime=Sat Mar 07 15:20:00 CST 2015, time=2015-03-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=17837, encodeId=87ba1e837bd, content=有市场, beContent=null, objectType=article, channel=null, level=null, likeNumber=153, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=hbwang006, createdTime=Fri Mar 06 19:20:00 CST 2015, time=2015-03-06, status=1, ipAttribution=)]
    2015-03-08 MedSci客户端网友

    希望越做越好!

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=34935, encodeId=bb3334935b9, content=投资很大哦, beContent=null, objectType=article, channel=null, level=null, likeNumber=201, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=332823945, createdName=hlycom3356, createdTime=Thu Aug 06 20:39:00 CST 2015, time=2015-08-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=17937, encodeId=4bd81e93714, content=恭喜!, beContent=null, objectType=article, channel=null, level=null, likeNumber=200, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=MedSci客户端网友, createdTime=Sun Mar 08 12:52:00 CST 2015, time=2015-03-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=17938, encodeId=97ff1e938bd, content=希望越做越好!, beContent=null, objectType=article, channel=null, level=null, likeNumber=155, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=MedSci客户端网友, createdTime=Sun Mar 08 12:52:00 CST 2015, time=2015-03-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=17924, encodeId=c82a1e9247b, content=恭喜MedSci, beContent=null, objectType=article, channel=null, level=null, likeNumber=146, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=223.104.5.**, createdTime=Sun Mar 08 10:33:00 CST 2015, time=2015-03-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1530405, encodeId=61cc153040507, content=<a href='/topic/show?id=8309e5153aa' target=_blank style='color:#2F92EE;'>#移动医疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=75153, encryptionId=8309e5153aa, topicName=移动医疗)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fbd812108434, createdName=yahu, createdTime=Sun Mar 08 05:09:00 CST 2015, time=2015-03-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1606427, encodeId=5493160642ed5, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Sun Mar 08 05:09:00 CST 2015, time=2015-03-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=17869, encodeId=8e761e86917, content=恭喜medsci, beContent=null, objectType=article, channel=null, level=null, likeNumber=134, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=drhqh240, createdTime=Sat Mar 07 15:20:00 CST 2015, time=2015-03-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=17837, encodeId=87ba1e837bd, content=有市场, beContent=null, objectType=article, channel=null, level=null, likeNumber=153, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=hbwang006, createdTime=Fri Mar 06 19:20:00 CST 2015, time=2015-03-06, status=1, ipAttribution=)]
    2015-03-08 223.104.5.**

    恭喜MedSci

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=34935, encodeId=bb3334935b9, content=投资很大哦, beContent=null, objectType=article, channel=null, level=null, likeNumber=201, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=332823945, createdName=hlycom3356, createdTime=Thu Aug 06 20:39:00 CST 2015, time=2015-08-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=17937, encodeId=4bd81e93714, content=恭喜!, beContent=null, objectType=article, channel=null, level=null, likeNumber=200, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=MedSci客户端网友, createdTime=Sun Mar 08 12:52:00 CST 2015, time=2015-03-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=17938, encodeId=97ff1e938bd, content=希望越做越好!, beContent=null, objectType=article, channel=null, level=null, likeNumber=155, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=MedSci客户端网友, createdTime=Sun Mar 08 12:52:00 CST 2015, time=2015-03-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=17924, encodeId=c82a1e9247b, content=恭喜MedSci, beContent=null, objectType=article, channel=null, level=null, likeNumber=146, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=223.104.5.**, createdTime=Sun Mar 08 10:33:00 CST 2015, time=2015-03-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1530405, encodeId=61cc153040507, content=<a href='/topic/show?id=8309e5153aa' target=_blank style='color:#2F92EE;'>#移动医疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=75153, encryptionId=8309e5153aa, topicName=移动医疗)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fbd812108434, createdName=yahu, createdTime=Sun Mar 08 05:09:00 CST 2015, time=2015-03-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1606427, encodeId=5493160642ed5, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Sun Mar 08 05:09:00 CST 2015, time=2015-03-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=17869, encodeId=8e761e86917, content=恭喜medsci, beContent=null, objectType=article, channel=null, level=null, likeNumber=134, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=drhqh240, createdTime=Sat Mar 07 15:20:00 CST 2015, time=2015-03-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=17837, encodeId=87ba1e837bd, content=有市场, beContent=null, objectType=article, channel=null, level=null, likeNumber=153, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=hbwang006, createdTime=Fri Mar 06 19:20:00 CST 2015, time=2015-03-06, status=1, ipAttribution=)]
    2015-03-08 yahu
  6. [GetPortalCommentsPageByObjectIdResponse(id=34935, encodeId=bb3334935b9, content=投资很大哦, beContent=null, objectType=article, channel=null, level=null, likeNumber=201, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=332823945, createdName=hlycom3356, createdTime=Thu Aug 06 20:39:00 CST 2015, time=2015-08-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=17937, encodeId=4bd81e93714, content=恭喜!, beContent=null, objectType=article, channel=null, level=null, likeNumber=200, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=MedSci客户端网友, createdTime=Sun Mar 08 12:52:00 CST 2015, time=2015-03-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=17938, encodeId=97ff1e938bd, content=希望越做越好!, beContent=null, objectType=article, channel=null, level=null, likeNumber=155, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=MedSci客户端网友, createdTime=Sun Mar 08 12:52:00 CST 2015, time=2015-03-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=17924, encodeId=c82a1e9247b, content=恭喜MedSci, beContent=null, objectType=article, channel=null, level=null, likeNumber=146, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=223.104.5.**, createdTime=Sun Mar 08 10:33:00 CST 2015, time=2015-03-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1530405, encodeId=61cc153040507, content=<a href='/topic/show?id=8309e5153aa' target=_blank style='color:#2F92EE;'>#移动医疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=75153, encryptionId=8309e5153aa, topicName=移动医疗)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fbd812108434, createdName=yahu, createdTime=Sun Mar 08 05:09:00 CST 2015, time=2015-03-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1606427, encodeId=5493160642ed5, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Sun Mar 08 05:09:00 CST 2015, time=2015-03-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=17869, encodeId=8e761e86917, content=恭喜medsci, beContent=null, objectType=article, channel=null, level=null, likeNumber=134, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=drhqh240, createdTime=Sat Mar 07 15:20:00 CST 2015, time=2015-03-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=17837, encodeId=87ba1e837bd, content=有市场, beContent=null, objectType=article, channel=null, level=null, likeNumber=153, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=hbwang006, createdTime=Fri Mar 06 19:20:00 CST 2015, time=2015-03-06, status=1, ipAttribution=)]
  7. [GetPortalCommentsPageByObjectIdResponse(id=34935, encodeId=bb3334935b9, content=投资很大哦, beContent=null, objectType=article, channel=null, level=null, likeNumber=201, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=332823945, createdName=hlycom3356, createdTime=Thu Aug 06 20:39:00 CST 2015, time=2015-08-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=17937, encodeId=4bd81e93714, content=恭喜!, beContent=null, objectType=article, channel=null, level=null, likeNumber=200, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=MedSci客户端网友, createdTime=Sun Mar 08 12:52:00 CST 2015, time=2015-03-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=17938, encodeId=97ff1e938bd, content=希望越做越好!, beContent=null, objectType=article, channel=null, level=null, likeNumber=155, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=MedSci客户端网友, createdTime=Sun Mar 08 12:52:00 CST 2015, time=2015-03-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=17924, encodeId=c82a1e9247b, content=恭喜MedSci, beContent=null, objectType=article, channel=null, level=null, likeNumber=146, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=223.104.5.**, createdTime=Sun Mar 08 10:33:00 CST 2015, time=2015-03-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1530405, encodeId=61cc153040507, content=<a href='/topic/show?id=8309e5153aa' target=_blank style='color:#2F92EE;'>#移动医疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=75153, encryptionId=8309e5153aa, topicName=移动医疗)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fbd812108434, createdName=yahu, createdTime=Sun Mar 08 05:09:00 CST 2015, time=2015-03-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1606427, encodeId=5493160642ed5, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Sun Mar 08 05:09:00 CST 2015, time=2015-03-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=17869, encodeId=8e761e86917, content=恭喜medsci, beContent=null, objectType=article, channel=null, level=null, likeNumber=134, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=drhqh240, createdTime=Sat Mar 07 15:20:00 CST 2015, time=2015-03-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=17837, encodeId=87ba1e837bd, content=有市场, beContent=null, objectType=article, channel=null, level=null, likeNumber=153, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=hbwang006, createdTime=Fri Mar 06 19:20:00 CST 2015, time=2015-03-06, status=1, ipAttribution=)]
    2015-03-07 drhqh240

    恭喜medsci

    0

  8. [GetPortalCommentsPageByObjectIdResponse(id=34935, encodeId=bb3334935b9, content=投资很大哦, beContent=null, objectType=article, channel=null, level=null, likeNumber=201, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=332823945, createdName=hlycom3356, createdTime=Thu Aug 06 20:39:00 CST 2015, time=2015-08-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=17937, encodeId=4bd81e93714, content=恭喜!, beContent=null, objectType=article, channel=null, level=null, likeNumber=200, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=MedSci客户端网友, createdTime=Sun Mar 08 12:52:00 CST 2015, time=2015-03-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=17938, encodeId=97ff1e938bd, content=希望越做越好!, beContent=null, objectType=article, channel=null, level=null, likeNumber=155, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=MedSci客户端网友, createdTime=Sun Mar 08 12:52:00 CST 2015, time=2015-03-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=17924, encodeId=c82a1e9247b, content=恭喜MedSci, beContent=null, objectType=article, channel=null, level=null, likeNumber=146, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=223.104.5.**, createdTime=Sun Mar 08 10:33:00 CST 2015, time=2015-03-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1530405, encodeId=61cc153040507, content=<a href='/topic/show?id=8309e5153aa' target=_blank style='color:#2F92EE;'>#移动医疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=75153, encryptionId=8309e5153aa, topicName=移动医疗)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fbd812108434, createdName=yahu, createdTime=Sun Mar 08 05:09:00 CST 2015, time=2015-03-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1606427, encodeId=5493160642ed5, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Sun Mar 08 05:09:00 CST 2015, time=2015-03-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=17869, encodeId=8e761e86917, content=恭喜medsci, beContent=null, objectType=article, channel=null, level=null, likeNumber=134, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=drhqh240, createdTime=Sat Mar 07 15:20:00 CST 2015, time=2015-03-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=17837, encodeId=87ba1e837bd, content=有市场, beContent=null, objectType=article, channel=null, level=null, likeNumber=153, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=hbwang006, createdTime=Fri Mar 06 19:20:00 CST 2015, time=2015-03-06, status=1, ipAttribution=)]
    2015-03-06 hbwang006

    有市场

    0

相关资讯

11.11 MedSci 大活动---你来,就送

还在为积分不够而发愁吗,还在为没获得纪念版T恤而黯然神伤吗,只要你来,就有得送。 活动内容; 1,转发此微信,直接获得22个积分 2,转发到微信,微博并推荐10个好友关注,以下奖品任你选。 活动形式: 转发后,直接截图给我们,并留下您的联系方式(姓名+联系电话+邮箱+邮寄地址)  

疯狂开学party——“自定义”话题

疯狂开学party——“自定义”话题

有关MedSci资讯保护原创者版权的声明

首先,应该就是保护版权的这是一个大前提,只有保护版权,行业才能健康有序地发展。其次,MedSci也看到互联网上有大量不尊重版权的事实。大量MedSci原创稿件被未授权转载,甚至转载时抹去作者和来源信息。MedSci一直呼吁以及坚持尊重版权意识。MedSci早在2012年在业内率先提出转载时尊重版权的声明,并一直屡行://www.sandwebs.com/article/show_article.do?

重磅推出:MedSci APP上线啦!

MedSci APP 上线啦!MedSci APP 专为医学科研者定制的阅读APP。在这里,不仅有最新的临床医学循证信息,更有丰富实用的科研工具,为您展开不一样的科研旅程,使用更方便快捷 2015年,我们 MedSci APP正式上线啦,MedSci APP 结合了网页版所包含的所有内容,还增加了许多新功能,使用更方便快捷。感谢大家对MedSci的支持与关注,小编在此解说一下如何下载Me

学霸的神器--MedSci资讯APP使用手册

工欲善其事,必先利其器! 这年头做科研,没个秘密武器怎么混? MedSci倾力打造最新APP,以资讯为载体,集合各大医学工具,审度最新临床研究,挑战世界医学难题,让您科研之旅不那么一般! 说再多不如一键安装自己来体验! 首页展示:医学快讯实时更新,分科资讯目标精准。全站文章,在登陆条件下评论即可+2积分(PC端网站积分+1) 功能菜单:右侧功能菜单,包括MedSc

疯狂开学party——吐槽君专区

如果您是吐槽君,请务必来这里。如果吐槽能转化成能量,我将无所不能。 任务描述:学习生活工作中,总有一些不那么如意,悲催的事,似乎那些不如意的事更占篇幅。那么请来这里,一句话表达那些能让您嘴角抽搐或者想重新思考人生的事!

Baidu
map
Baidu
map
Baidu
map